Denis Smith Selected Research

Denis Smith Research Topics

Disease

31	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 12/2007
19	Neoplasm Metastasis (Metastasis) 12/2023 - 06/2004
13	Neoplasms (Cancer) 04/2024 - 02/2006
9	Adenocarcinoma 04/2024 - 02/2006
8	Disease Progression 04/2024 - 08/2017
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2024 - 08/2017
5	Microsatellite Instability 03/2023 - 12/2020
5	Pancreatic Neoplasms (Pancreatic Cancer) 09/2021 - 02/2006
4	Rectal Neoplasms (Rectal Cancer) 11/2023 - 01/2020
4	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2022 - 02/2011
4	Fatigue 01/2022 - 02/2011
3	Neutropenia 01/2023 - 09/2017
2	Colitis 04/2024 - 01/2022
2	Pathologic Complete Response 11/2023 - 11/2019
2	Neuroendocrine Carcinoma 01/2023 - 02/2018
2	Asthenia 01/2023 - 02/2011
2	Primitive Neuroectodermal Tumors (PNET) 01/2022 - 12/2021
2	Residual Neoplasm 01/2020 - 05/2016
2	Carcinoid Tumor (Carcinoid) 05/2016 - 12/2009
1	Anus Neoplasms (Anal Cancer) 04/2024
1	Sarcoidosis (Schaumann Disease) 04/2024
1	Infections 04/2024
1	Acute Kidney Injury (Acute Renal Failure) 04/2024
1	Necrolytic Migratory Erythema 12/2023
1	Weight Loss (Weight Reduction) 12/2023
1	Glucagonoma 12/2023
1	Carcinoma (Carcinomatosis) 07/2023
1	Ischemic Stroke 01/2023
1	Intestinal Perforation 01/2022
1	Vipoma (WDHA) 12/2021
1	Colonic Neoplasms (Colon Cancer) 03/2021
1	Rare Diseases (Rare Disease) 04/2020
1	Hemorrhagic Stroke 01/2020
1	Ischemia 01/2020
1	Mucositis 12/2019
1	Sarcoma (Soft Tissue Sarcoma) 01/2018
1	Multiple Endocrine Neoplasia Type 1 07/2016
1	Margins of Excision 05/2016

Drug/Important Bio-Agent (IBA)

16	Fluorouracil (Carac)FDA LinkGeneric 04/2024 - 06/2005
13	Bevacizumab (Avastin)FDA Link 03/2023 - 12/2014
10	Cisplatin (Platino)FDA LinkGeneric 04/2024 - 08/2006
9	Cetuximab (Erbitux)FDA Link 01/2024 - 05/2015
8	Irinotecan (Camptosar)FDA LinkGeneric 04/2024 - 03/2008
7	Docetaxel (Taxotere)FDA Link 04/2024 - 08/2017
7	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2023 - 12/2007
5	Leucovorin (Folinic Acid)FDA Link 04/2024 - 12/2011
5	pembrolizumabIBA 04/2024 - 12/2020
4	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 12/2023 - 01/2018
4	Everolimus FDA Link 01/2022 - 01/2018
4	Sunitinib (Sutent)FDA Link 01/2022 - 02/2011
4	folfirinoxIBA 01/2022 - 01/2019
3	PlatinumIBA 04/2024 - 02/2018
3	atezolizumabIBA 04/2024 - 04/2020
3	Gemcitabine FDA Link 05/2015 - 08/2006
2	Immune Checkpoint InhibitorsIBA 04/2024 - 01/2022
2	avelumabIBA 04/2024 - 01/2019
2	Carboplatin (JM8)FDA LinkGeneric 07/2023 - 02/2018
2	Etoposide (VP 16)FDA LinkGeneric 01/2023 - 02/2018
2	EnzymesIBA 12/2019 - 12/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2016 - 12/2014
2	Carcinoembryonic AntigenIBA 11/2016 - 06/2004
2	DNA (Deoxyribonucleic Acid)IBA 03/2008 - 12/2007
1	durvalumabIBA 04/2024
1	tremelimumabIBA 04/2024
1	LigandsIBA 04/2024
1	Programmed Cell Death 1 ReceptorIBA 04/2024
1	NivolumabIBA 04/2024
1	Glucagon (Glukagon)FDA Link 12/2023
1	LenograstimIBA 10/2023
1	Alanine Transaminase (SGPT)IBA 01/2022
1	XELOXIBA 01/2022
1	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 12/2021
1	N-acetyltalosaminuronic acid (NAT)IBA 09/2021
1	Panitumumab (Vectibix)FDA Link 01/2021
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	regorafenibIBA 11/2020
1	ErbB Receptors (EGF Receptor)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 11/2019
1	CreatinineIBA 01/2019
1	Immunoglobulin G (IgG)IBA 01/2019
1	Hemoglobins (Hemoglobin)IBA 01/2019
1	EpitopesIBA 01/2018
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 12/2017
1	Membrane Transport Proteins (Biological Pump)IBA 12/2017
1	Uridine Diphosphate (UDP)IBA 12/2017
1	Cytochrome P-450 CYP2C9IBA 09/2017
1	Cytochrome P-450 CYP2C19IBA 09/2017
1	Somatostatin Receptors (Somatostatin Receptor)IBA 07/2016
1	lanreotide (Somatuline)FDA Link 05/2016
1	Trastuzumab (Herceptin)FDA Link 05/2015

Therapy/Procedure

39	Drug Therapy (Chemotherapy) 04/2024 - 02/2006
16	Therapeutics 12/2023 - 12/2007
6	Radiotherapy 01/2022 - 02/2006
5	Neoadjuvant Therapy 11/2023 - 01/2019
5	Chemoradiotherapy 10/2021 - 02/2006
1	TP protocol 07/2023
1	Induction Chemotherapy 10/2021
1	Re-Irradiation 01/2021
1	Radiofrequency Ablation 01/2018